DK2063868T3 - Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium - Google Patents

Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium

Info

Publication number
DK2063868T3
DK2063868T3 DK07804524.2T DK07804524T DK2063868T3 DK 2063868 T3 DK2063868 T3 DK 2063868T3 DK 07804524 T DK07804524 T DK 07804524T DK 2063868 T3 DK2063868 T3 DK 2063868T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
rosuvastatin calcium
containing rosuvastatin
calcium
Prior art date
Application number
DK07804524.2T
Other languages
English (en)
Inventor
Maria Viragh
Iidiko Monostori
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK2063868T3 publication Critical patent/DK2063868T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07804524.2T 2006-09-18 2007-09-11 Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium DK2063868T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0600728A HU227610B1 (en) 2006-09-18 2006-09-18 Pharmaceutical compositions containing rosuvastatin potassium
PCT/HU2007/000082 WO2008035128A1 (en) 2006-09-18 2007-09-11 Pharmaceutical compositions containing rosuvastatin calcium

Publications (1)

Publication Number Publication Date
DK2063868T3 true DK2063868T3 (da) 2011-02-07

Family

ID=89987035

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07804524.2T DK2063868T3 (da) 2006-09-18 2007-09-11 Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium

Country Status (24)

Country Link
US (1) US8221788B2 (da)
EP (1) EP2063868B1 (da)
JP (1) JP5534812B2 (da)
CN (1) CN101516349A (da)
AR (1) AR062874A1 (da)
AT (1) ATE489078T1 (da)
AU (1) AU2007298751B2 (da)
CA (1) CA2662919C (da)
CY (1) CY1114533T1 (da)
DE (1) DE602007010797D1 (da)
DK (1) DK2063868T3 (da)
EA (1) EA014451B1 (da)
ES (1) ES2357263T3 (da)
HR (1) HRP20110125T1 (da)
HU (1) HU227610B1 (da)
JO (1) JO2641B1 (da)
ME (1) ME01944B (da)
PL (1) PL2063868T3 (da)
PT (1) PT2063868E (da)
RS (1) RS51563B (da)
SI (1) SI2063868T1 (da)
TW (1) TWI454265B (da)
UA (1) UA97489C2 (da)
WO (1) WO2008035128A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
TR200800269A2 (tr) * 2008-01-15 2009-08-21 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Stabil farmasötik formülasyon ve hazırlama yöntemleri
EP2815751A1 (en) 2008-01-28 2014-12-24 Beauty Pearl Group Limited Compositions comprising calcium, magnesium, zinc, and vitamin D3 for the prevention and amelioration of osteoporosis
WO2009112870A1 (en) * 2008-03-11 2009-09-17 Belupo-Lijekovi I Kozmetika D.D. Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer
EP2138165A1 (en) 2008-06-27 2009-12-30 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising a statin
SI2309992T1 (en) * 2008-06-27 2018-03-30 Krka, Tovarna Zdravil, D.D., Novo Mesto A pharmaceutical composition comprising a statin
PL386051A1 (pl) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stabilna doustna kompozycja farmaceutyczna zawierająca farmaceutycznie dopuszczalną sól kwsu [(E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo] (3R,5S)-3,5-dihydroksyhept-6-enowego
TR200904341A2 (tr) 2009-06-03 2010-12-21 Bi̇lgi̇ç Mahmut Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
WO2011139256A2 (en) 2010-05-04 2011-11-10 Bilgic Mahmut Stable rosuvastatin formulations
CN101972260B (zh) * 2010-11-24 2012-05-02 天津市汉康医药生物技术有限公司 一种瑞舒伐他汀钙口服药物组合物
US20140294959A1 (en) * 2011-05-20 2014-10-02 Astrazeneca Uk Limited Pharmaceutical Composition of Rosuvastatin Calcium
CN102860994B (zh) * 2011-07-04 2016-01-20 石药集团中奇制药技术（石家庄）有限公司 一种瑞舒伐他汀钙片及其制备方法
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
EP4345100A3 (en) * 2012-09-18 2024-04-10 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
CN102908335B (zh) * 2012-11-19 2015-04-08 山东罗欣药业集团股份有限公司 一种瑞舒伐他汀钙组合物及其制备方法
CN103961354A (zh) * 2013-02-05 2014-08-06 深圳信立泰药业股份有限公司 一种稳定的瑞舒伐他汀钙药物组合物及其制备方法
RO129060B1 (ro) 2013-04-25 2014-11-28 Antibiotice S.A. Compoziţie farmaceutică stabilă cu rosuvastatină calcică amorfă
RU2547574C2 (ru) * 2013-07-09 2015-04-10 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма гиполипидемического действия и способ ее изготовления
CN103494788B (zh) * 2013-10-10 2015-08-05 齐晓彤 瑞舒伐他汀钙片的药物组合物及其制备方法
WO2015084622A1 (en) 2013-12-03 2015-06-11 Auspex Pharmaceuticals, Inc. Methods of manufacturing benzoquinoline compounds
JP6075818B2 (ja) * 2014-11-11 2017-02-08 塩野義製薬株式会社 光に対して不安定な薬物を含有する多層錠剤
CN104523650B (zh) * 2014-12-20 2017-04-12 山东新时代药业有限公司 一种含有瑞舒伐他汀钙的胶囊
AU2016229949B2 (en) 2015-03-06 2021-04-08 Auspex Pharmaceuticals Llc Methods for the treatment of abnormal involuntary movement disorders
JP2016169198A (ja) * 2015-03-13 2016-09-23 大原薬品工業株式会社 ロスバスタチンカルシウムを含有する錠剤
JP6095176B2 (ja) * 2015-04-24 2017-03-15 大原薬品工業株式会社 ロスバスタチンカルシウムの光安定性が向上したフィルムコーティング錠剤
CN104840964B (zh) * 2015-05-07 2018-01-16 南京正大天晴制药有限公司 一种稳定的索氟布韦药物组合物及其制备方法
CN105168158B (zh) * 2015-08-18 2018-08-03 上海韬鸿化工科技有限公司 一种瑞舒伐他汀钙分散片及其制备方法
EP3243506A1 (en) 2016-05-09 2017-11-15 Adamed sp. z o.o. Pharmaceutical composition
CN108245516B (zh) * 2017-11-09 2019-04-12 浙江京新药业股份有限公司 一种含瑞舒伐他汀钙的药物组合物及其制备方法
CN112274487A (zh) * 2019-07-25 2021-01-29 北京福元医药股份有限公司 一种瑞舒伐他汀钙药物制剂
CN115317455B (zh) * 2022-08-17 2023-08-22 新发药业有限公司 一种药片含量均匀、易于溶出的瑞舒伐他汀钙片及其制备方法
GB2622822A (en) 2022-09-28 2024-04-03 Novumgen Ltd A rapidly disintegrating tablet of rosuvastatin and its process of preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija
US6569461B1 (en) * 1999-03-08 2003-05-27 Merck & Co., Inc. Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
US6478979B1 (en) * 1999-07-20 2002-11-12 3M Innovative Properties Company Use of fluorinated ketones in fire extinguishing compositions
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20030031720A1 (en) * 2000-02-24 2003-02-13 Tobias Laich Method for producing pharmaceutical dosage forms
GB0111077D0 (en) * 2001-05-04 2001-06-27 Biochemie Gmbh Organic compounds
WO2003068191A1 (en) * 2002-02-14 2003-08-21 Ranbaxy Laboratories Limited Formulations of atorvastatin stabilized with alkali metal additions
GB0217306D0 (en) * 2002-07-25 2002-09-04 Novartis Ag Compositions comprising organic compounds
SI21400A (sl) 2003-02-12 2004-08-31 LEK farmacevtska družba d.d. Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze
WO2005021511A1 (en) * 2003-08-27 2005-03-10 Hetero Drugs Limited A novel process for amorphous rosuvastatin calcium
RU2007133601A (ru) * 2005-02-10 2009-03-20 Лайфсайкл Фарма А/С (Dk) УСТОЙЧИВАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ФИКСИРОВАННУЮ ДОЗУ КОМБИНАЦИИ ФЕНОФИБРАТА И ИНГИБИТОРА HMG-CoA-РЕДУКТАЗЫ
EP1905424A3 (en) * 2006-02-02 2008-04-30 Ranbaxy Laboratories Limited Process for the preparation of a pharmaceutical composition comprising stabilized statin particles

Also Published As

Publication number Publication date
US8221788B2 (en) 2012-07-17
EA200970291A1 (ru) 2009-06-30
TWI454265B (zh) 2014-10-01
HUP0600728A2 (en) 2008-06-30
UA97489C2 (ru) 2012-02-27
AU2007298751A1 (en) 2008-03-27
CN101516349A (zh) 2009-08-26
HU227610B1 (en) 2011-09-28
TW200829246A (en) 2008-07-16
PL2063868T3 (pl) 2011-05-31
JP5534812B2 (ja) 2014-07-02
ES2357263T3 (es) 2011-04-20
JO2641B1 (en) 2012-06-17
RS51563B (sr) 2011-08-31
ME01944B (me) 2011-08-31
CY1114533T1 (el) 2016-10-05
CA2662919A1 (en) 2008-03-27
CA2662919C (en) 2013-04-30
HU0600728D0 (en) 2006-11-28
PT2063868E (pt) 2010-12-23
DE602007010797D1 (de) 2011-01-05
AR062874A1 (es) 2008-12-10
EP2063868B1 (en) 2010-11-24
US20090297599A1 (en) 2009-12-03
ATE489078T1 (de) 2010-12-15
EP2063868A1 (en) 2009-06-03
WO2008035128A1 (en) 2008-03-27
SI2063868T1 (sl) 2011-03-31
HRP20110125T1 (hr) 2011-03-31
EA014451B1 (ru) 2010-12-30
JP2010503723A (ja) 2010-02-04
AU2007298751B2 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0715712A2 (pt) Composição farmacêutica
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
BRPI0719393A2 (pt) Composição farmacêutica
DK2041139T3 (da) Farmaceutiske forbindelser
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0721651A2 (pt) Composição farmacêutica
RU2493831C3 (ru) Фармацевтические композиции
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
EP2124556A4 (en) PHARMACEUTICAL COMPOSITIONS
ATE493119T1 (de) Pharmazeutische zusammensetzung
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0820198A2 (pt) composições farmacêuticas
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
IL210102A0 (en) Pharmaceutical compositions of rosuvastatin calcium
EP2116241A4 (en) PHARMACEUTICAL COMPOSITION
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0820839A2 (pt) Composição farmacêutica
ITMI20061734A1 (it) Composizione farmaceutica
ITRC20060025A1 (it) Composizione farmaceutica
ITRC20060024A1 (it) Composizione farmaceutica